BIOLASE, INC 4
4 · BIOLASE, INC · Filed Apr 19, 2017
Insider Transaction Report
Form 4
BIOLASE, INCBIOL
Flynn Harold C Jr.
DirectorPresident and CEO
Transactions
- Purchase
Warrants (right to buy)
2017-04-18$0.13/sh+14,945$1,868→ 14,945 total(indirect: By Trust)Exercise: $1.80From: 2017-10-18Exp: 2022-04-18→ Common Stock (14,945 underlying) - Purchase
Series D Participating Convertible Preferred Stock
2017-04-18$124.00/sh+307$38,068→ 307 total(indirect: By Trust)→ Common Stock (30,700 underlying)
Footnotes (4)
- [F1]These shares of Series D Participating Convertible Preferred Stock ("Preferred Stock") and Warrants were acquired by the Flynn Living Trust (the "Trust") in a private placement with the Issuer that closed on April 18, 2017 (the "Closing").
- [F2]Each share of Preferred Stock will initially be convertible into 100 shares of Common Stock ("Shares"), reflecting a conversion price equal to $1.24 per Share. The conversion of the Preferred Stock will occur automatically upon the Requisite Stockholder Approval (defined and described further in the Securities Purchase Agreement dated April 11, 2017 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on April 14, 2017), which is expected to occur after the Closing. The Preferred Stock has no expiration date.
- [F3]The Preferred Stock and Warrants are held directly by the Trust. Mr. Flynn serves as a co-trustee to the Trust and his daughter is the beneficiary of the Trust.
- [F4]The Reporting Person disclaims beneficial ownership of the Preferred Stock and Warrants except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Preferred Stock or Warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.